EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Deciphering the MYCN-driven metabolic microenvironment of neuroblastoma

Amber Wolf, Davide Leardini, Lingzhi Li, Riccardo Masetti, Costas A Lyssiotis, Eveline Barbieri

Trends in Molecular Medicine · 2026

DOI: 10.1016/j.molmed.2025.08.005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Trends in Molecular Medicine, 2026. Verfasst von Amber Wolf und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA. Hauptthemen laut MEDLINE: N-Myc Proto-Oncogene Protein, Tumor Microenvironment, Neuroblastoma. Die Arbeit nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, US Department of Defense.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oncogenic MYCN drives aggressive disease in many cancers including neuroblastoma (NB). Metabolic reprogramming is essential to support cancer cell homeostasis and survival under nutrient- and oxygen-deprived conditions. MYCN directly reprograms many nodes of tumor-intrinsic metabolism, which have significant repercussions on the cells of the tumor microenvironment (TME), resulting in complex intercellular metabolic circuits that contribute to the immunosuppressive microenvironment of NB. These metabolic circuits are also regulated by the organismal and cellular circadian clock and host diet to further impact the TME and NB oncogenesis. This review discusses the mechanisms by which MYCN regulates the metabolic crosstalk between tumor, TME, and host, and provides evidence that therapeutic targeting of MYCN-reprogrammed metabolism can improve patient outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

N-Myc Proto-Oncogene ProteinTumor MicroenvironmentNeuroblastomaHumansAnimals

Stichwörter der Autor:innen

MYCNmetabolismneuroblastomatumor microenvironment

Substanzen

N-Myc Proto-Oncogene ProteinMYCN protein, human

Autor:innen und Institutionen

  • Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA.
  • Pediatric Hematology and Oncology, IRCCS Azienda Ospedaliero, Universitaria di Bologna, Bologna, Italy.
  • Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI, USA.
  • Department of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer and Hematology Center, Baylor College of Medicine, Houston, TX, USA. Electronic address: exbarbie@texaschildrens.org.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • US Department of Defense
  • Baylor College of Medicine
  • Cancer Prevention and Research Institute of Texas

Zitieren

APA

Wolf, A., Leardini, D., Li, L., Masetti, R., Lyssiotis, C. A., & Barbieri, E. (2026). Deciphering the MYCN-driven metabolic microenvironment of neuroblastoma. Trends in Molecular Medicine. https://doi.org/10.1016/j.molmed.2025.08.005

Vancouver

Wolf A, Leardini D, Li L, Masetti R, Lyssiotis CA, Barbieri E. Deciphering the MYCN-driven metabolic microenvironment of neuroblastoma. Trends in Molecular Medicine. 2026. doi:10.1016/j.molmed.2025.08.005

BibTeX
@article{Wolf2026,
  author = {Wolf, Amber and Leardini, Davide and Li, Lingzhi and Masetti, Riccardo and Lyssiotis, Costas A and Barbieri, Eveline},
  title = {Deciphering the MYCN-driven metabolic microenvironment of neuroblastoma},
  journal = {Trends in Molecular Medicine},
  year = {2026},
  doi = {10.1016/j.molmed.2025.08.005}
}
Kostenlos starten →